Clinical Trial Update: Efficacy and Safety of Prophylactic Treatment for Pneumocystis Jirovecii Pneumonia in Patients With Autoimmune Inflammatory Rheumatic Disease [Phase 4]

View source ↗

Summary

Clinical trial update for a Phase 4 study evaluating prophylactic treatment to prevent Pneumocystis jirovecii pneumonia in patients with autoimmune inflammatory…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Diseases
• Pneumocystis Pneumonia

Snippet

Sponsor: Tongji Hospital | Conditions: Pneumonia, Pneumocystis, Autoimmune Inflammatory Rheumatic Disease | Phase 4 | Status: RECRUITING